In fact, miR-155 has been implicated in cell cycle control by the inhibition of tumor-suppressor molecules, such as TP53 and cyclin/cyclin-dependent kinases (CDK) [15,18,19,20,59]. This evidence concerns the gene TP53 and neoplasm.